Erratum to: Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process (Scientific Reports, (2015), 4, 1, (3852), 10.1038/srep03852);Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Tsuno, Satoshi ^a   Wang, Xinhui ^a   Shomori, Kohei ^b   Hasegawa, Junichi ^a   Miura, Norimasa ^a  

^a Department of Pathophysiological and Therapeutic Science   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; ALB PROTEIN, HUMAN; CYTOSINE; DRUG DERIVATIVE; ELAVL2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HU ANTIGEN; MICRORNA; MIRN520 MICRORNA, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; PROTEIN P53; SERUM ALBUMIN; SMALL INTERFERING RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETICS; HEK293 CELL LINE; HUMAN; LENTIVIRINAE; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLOMICS; MOUSE; PLURIPOTENT STEM CELL; RNA INTERFERENCE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSINE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HOMEODOMAIN PROTEINS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LENTIVIRUS; LIVER; LIVER NEOPLASMS; METABOLOMICS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERUM ALBUMIN; TELOMERASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84893132040     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-32380-8     Document Type: Erratum

References (51)

1. Lee, Y. et al. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670 (2002)
2. Zeng, Y. & Cullen, B. R. Sequence requirements for micro RNA processing and function in human cells. RNA 9, 112-123 (2003)
3. Farazi, T. A., Spitzer, J. I., Morozov, P. & Tuschl, T. X. miRNA in human cancer. J. Pathol. 223, 102-15 (2011)
4. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010)
5. Lee, Y. S. & Dutta, A. MicroRNAs: small but potent oncogenes or tumor suppressors. Curr. Opin. Investig. Drugs 7, 560-564 (2006)
6. Lai, E. C. Micro RNAs are complementary to 39UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30, 363-364 (2002)
7. Saetrom,O., Snøve, O. Jr.&Saetrom, P.Weighted sequencemotifs as an improved seeding step in microRNA target prediction algorithms. RNA 11, 995-1003 (2005)
8. Meltzer, P. S. Cancer genomics: small RNAs with big impacts. Nature 435, 745-746 (2005)
9. Calin, G. A. et al.MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101, 11755-11760 (2004)
10. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005)
11. Li, Z., Yang, C. S., Nakashima, K. & Rana, T. M. Small RNA-mediated regulation of iPS cell generation. EMBO J. 30, 823-834 (2011)
12. Lin, S. L. et al.Mir-302 reprograms human skin cancer cells into a pluripotent EScell- like state. RNA 14, 2115-2124 (2008)
13. Lowery, A. J. et al.MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res. 11, R27 (2009)
14. Miura, N. et al. A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT. BMC Mol. Biol. 2, 10:5 (2009)
15. Panopoulos, A. D. et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 22, 168-177 (2012)
16. Ghildiyal, M. & Zamore, P. D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10, 94-108 (2009)
17. Ladeiro, Y. et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963 (2008)
18. Farazi, T. A., Hoell, J. I., Morozov, P. & Tuschl, T. MicroRNAs in human cancer. Adv. Exp. Med. Biol. 774, 1-20 (2013)
19. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005)
20. Goodarzi, H., Elemento, O. & Tavazoie, S. Revealing global regulatory perturbations across human cancers. Mol. Cell 36, 900-911 (2009)
21. Okita, K., Ichisaka, T.&Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007)
22. Fujioka, T. et al. Establishment of induced pluripotent stem cells from human neonatal tissues. Hum. Cell 23, 113-118 (2010)
23. Yehezkel, S. et al. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 21, 6 (2010)
24. Bhutani, N. et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047 (2010)
25. De Carvalho, D. D., You, J. S. & Jones, P. A. DNA methylation and cellular reprogramming. Trends Cell Biol. 20, 609-617 (2010)
26. Saito, Y. et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer 105, 527-532 (2003)
27. Tatemichi, M., Hata, H. & Nakadate, T. Ectopic expression of activation-induced cytidine deaminase caused by epigenetics modification. Oncol. Rep. 25, 153-158 (2011)
28. Gunaratne, P. H. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells? Curr. Stem Cell Res. Ther. 4, 168-177 (2009)
29. Sen, G. L. et al. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 463, 563-567 (2010)
30. Nascimento, E. M., Cox, C. L., MacArthur, S., Hussain, S., Trotter, M. et al. The opposing transcriptional functions of Sin3a and c-Myc are required to maintain tissue homeostasis. Nat. Cell Biol. 13, 1395-1405 (2011)
31. Lin, S. L. et al. Regulation of somatic cell reprogramming through inducible mir- 302 expression. Nucleic Acids Res. 39, 1054-1065 (2010)
32. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009)
33. Zhu, Z. et al. Cancer stem/progenitor cells are highly enriched in CD1331CD441 population in hepatocellular carcinoma. Int. J. Cancer 126, 2067-2078 (2010)
34. Henry, J. C. et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 403, 120-125 (2010)
35. Liu, T. et al. High efficiency of reprogramming CD341 cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4. Stem Cells Dev. 21, 2322-2332 (2012)
36. Sand, M. et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest. 28, 649-653 (2010)
37. Chen, M. et al. Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One 7, e28203 (2012)
38. Plaisant, M. et al. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem Cells 27, 703-713 (2009)
39. Tsai, C. C. et al.Oct4 and Nanog directly regulate Dnmt1 tomaintain self-renewal and undifferentiated state in mesenchymal stem cells. Molecular Cell 47, 169-182 (2012)
40. Takai, A. et al. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene 28, 1469-1478 (2009)
41. Han, J., Sachdev, P. S. & Sidhu, K. S. A combined epigenetic and non-genetic approach for reprogramming human somatic cells. PLoS One 5, e12297 (2010)
42. Mitchell, N. E. et al. Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis. Epigenomics 5, 155-165 (2013)
43. Zhang, D. et al. AMD1 is essential for ESC self-renewal and is translationally down-regulated on differentiation to neural precursor cells. Genes Dev. 26, 461-473 (2012)
44. Hirayama, A. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925 (2009)
45. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008)
46. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007)
47. Miura, N. et al. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci. 97, 1366-1373 (2006)
48. Shomori, K. et al. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: role of p53 expression. Pathol. Int. 49, 491-499 (1999)
49. Ohashi, Y. et al. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol. Biosyst. 4, 135-147 (2008)
50. Baran, R. et al. MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics 13, 7:530 (2006)
51. Klukas, C. & Schreiber, F. Integration of -omics data and networks for biomedical research with VANTED. J. Integr. Bioinform. 2, 7:112 (2010)